Magnetar Financial’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-392,001
| Closed | -$3.93K | – | 1791 |
|
|
2022
Q2 | $3.93K | Sell |
392,001
-57,999
| -13% | -$581 | 0.04% | 373 |
|
|
2022
Q1 | $4.45M | Sell |
450,000
-657
| -0.1% | -$6.49K | 0.05% | 393 |
|
|
2021
Q4 | $4.5M | Sell |
450,657
-4,000
| -0.9% | -$39.9K | 0.05% | 410 |
|
|
2021
Q3 | $4.53M | Hold |
454,657
| – | – | 0.05% | 393 |
|
|
2021
Q2 | $4.63K | Buy |
454,657
+4,657
| +1% | +$47 | 0.04% | 394 |
|
|
2021
Q1 | $4.54M | Sell |
450,000
-50,000
| -10% | -$505K | 0.04% | 365 |
|
|
2020
Q4 | $5.26M | Buy |
+500,000
| New | +$5.26M | 0.07% | 242 |
|